Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields.... Show more
Segments: Consumer; Pharmaceutical; Medical Devices
Rating: Strong Buy

Johnson & Johnson Financial Health

Profitability:8.47/10

Johnson & Johnson has better Profitability than 66.67% of the companies on the Drug Manufacturers industry

Net Margin: 20.75%

Johnson & Johnson has better Net Margin than 58.33% of the companies on the Drug Manufacturers industry


ROE (Return on Equity): 0%

Johnson & Johnson has better ROE (Return on Equity) than 100% of the companies on the Drug Manufacturers industry


ROA (Return on Assets): 2.75%

Johnson & Johnson has better ROA (Return on Assets) than 66.67% of the companies on the Drug Manufacturers industry


Operating Efficiency:9.44/10

Johnson & Johnson has better Operating Efficiency than 58.33% of the companies on the Drug Manufacturers industry

Operating Margin: 40.1%

Johnson & Johnson has better Operating Margin than 58.33% of the companies on the Drug Manufacturers industry


Liquidity:4.75/10

Johnson & Johnson has better Liquidity than 58.33% of the companies on the Drug Manufacturers industry

Quick Ratio: 1.05

Johnson & Johnson has better Quick Ratio than 58.33% of the companies on the Drug Manufacturers industry


Operating Cash Flow Ratio: 0.69

Johnson & Johnson has better Operating Cash Flow Ratio than 66.67% of the companies on the Drug Manufacturers industry


Solvency:8.03/10

Johnson & Johnson has better Solvency than 83.33% of the companies on the Drug Manufacturers industry

Debt to Equity Ratio: 0.45

Johnson & Johnson has better Debt to Equity Ratio than 75% of the companies on the Drug Manufacturers industry


Interest Coverage Ratio: 0.69

Johnson & Johnson has better Interest Coverage Ratio than 66.67% of the companies on the Drug Manufacturers industry


Johnson & Johnson revenue by location
Johnson & Johnson revenue by segment
Johnson & Johnson revenue quarter by quarter
Johnson & Johnson operating expenses

👀 Get a summary of every week for free

Top company news, earnings report, analysis and more.

InspectCompany.com

We aim to help investors learn more about the companies in which they invest. We believe investing should be less about trying to find patterns in charts and more about investing in the companies that better represent your vision for the future.

Disclaimer: InspectCompany does not guarantee that any of the information available on our website, APIs or provided by any other means is complete, accurate, current, reliable or appropriate for your needs. Some of our information is provided by third party services and we cannot guarantee that is complete, accurate, current, reliable or appropriate for your needs. The information and recommendations on this site are for educational purposes only and should not be used to replace the advice of financial advisors and other professionals. All our services, information, data and/or recommendations are provided on an "as is" basis and without warranties of any kind, either express or implied. We do not guarantee that our services, information, data and/or recommendations are complete, accurate, current, reliable or appropriate for your needs.  Read more